20152018

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 3 Conference contribution
  • 2 Article
  • 1 Meeting abstract
2018

Targeting the dopamine receptor 2 in BRAF mutant colorectal cancer

Javadi, A., Forsythe, N., Refaat, A., Weir, J-A., Khawaja, H., Waugh, D., Tarapore, R., Allen, J. E., Johnston, P. & Van Schaeybroeck, S., Jul 2018, In : Cancer Research. 78, Issue 13 Supplement, 1 p., Abstract 3448.

Research output: Contribution to journalMeeting abstract

The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer

Forsythe, N., Refaat, A., Javadi, A., Khawaja, H., Weir, J-A., Emam, H., Allen, W. L., Burkamp, F., Popovici, V., Jithesh, P. V., Isella, C., Labonte, M. J., Mills, I. G., Johnston, P. G. & Van Schaeybroeck, S., 26 Feb 2018, In : Molecular Cancer Therapeutics.

Research output: Contribution to journalArticle

Open Access
File
4 Citations (Scopus)
301 Downloads (Pure)
2017

The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer

Van Schaeybroeck, S., Forsythe, N., Refaat, A., Javadi, A., Khawaja, H., Weir, J-A., Emam, H., Moore, W., Burkamp, F., Popovici, V., Jithesh, P., Isella, C., LaBonte Wilson, M., Mills, I. & Johnston, P., 2017, The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer. National Cancer Research Insitute

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2016

ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.

Weir, J-A., Gilliland, P., Fuchs, M-A., Williams, R., Murray, L., Johnston, P. & Van Schaeybroeck, S., Nov 2016, ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.. National Cancer Research Institute

Research output: Chapter in Book/Report/Conference proceedingConference contribution

EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer

Dunne, P. D., Dasgupta, S., Blayney, J. K., McArt, D. G., Redmond, K. L., Weir, J-A., Bradley, C. A., Sasazuki, T., Shirasawa, S., Wang, T., Srivastava, S., Ong, C. W., Arthur, K., Salto-Tellez, M., Wilson, R. H., Johnston, P. G. & Van Schaeybroeck, S., 01 Jan 2016, In : Clinical Cancer Research. 22, 1, p. 230-242 13 p.

Research output: Contribution to journalArticle

55 Citations (Scopus)
2015

The role of micro-environment-derived ligands in resistance to EGFR monoclonal antibodies in KRAS wild type colorectal cancer

Weir, J-A., Redmond, K., Bradley, C. & Van Schaeybroeck, S., Nov 2015, The role of micro-environment-derived ligands in resistance to EGFR monoclonal antibodies in KRAS wild type colorectal cancer. National Cancer Research Institute, Vol. A87.

Research output: Chapter in Book/Report/Conference proceedingConference contribution